Maze Therapeutics MAZE Edges Higher Consolidating Between Support and Resistance Endurance Technologies IPO Opens A Potential Test of Investor Appetite CMSD Q1 2026 Earnings EPS Beats Estimates on Operational Strength Chinas OilBuying Pause Signals Potential Market Shift Analysts Suggest